Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Robert James Chambers is active.

Publication


Featured researches published by Robert James Chambers.


Synthetic Communications | 1989

A Stereooontrolled Approach to Tri and Tetrasubstttuted Cyclohexanones

Phillip A. Zoretic; Scott H. Dickerson; Byung-Chan Yu; Michael S. Biggers; Robert James Chambers; Christopher K. Biggers; Myron L. Caspar

Abstract A series of reactions utilizing acetals 2–5 with organo cuprates was studied to determine the stereoselectivity of the 1,4-conjugate addition. A90:10 stereoselectivity was observed from the reaction of lithium or bromomagnesium divinyl cuprate with acetal 5 which generated a facile entry to the tetrasubstituted cyclohexanone via a consecutive 1,4-conjugate addition - 1,3-alkylation sequence.


Expert Opinion on Therapeutic Patents | 1999

Leukotriene antagonists: patent highlights 1996 - 1998

Robert James Chambers; Anthony Marfat

Antagonists of leukotriene D4 (LTD4) have shown clinical efficacy in the treatment of asthma while efficacy with antagonists of leukotriene B4 (LTB4) has yet to be demonstrated. The development of dual mediators possessing either histamine (H1), thromboxane (TXA2), or serine protease activity coupled with leukotriene antagonist activity offers a new direction of research, one which offers the greatest potential in discovering a superior agent for the treatment of allergic and inflammatory diseases.


Journal of Medicinal Chemistry | 1996

Biarylcarboxylic acids and -amides : inhibition of phosphodiesterase type IV versus [3H]rolipram binding activity and their relationship to emetic behavior in the ferret

Allen J. Duplantier; Michael S. Biggers; Robert James Chambers; John B. Cheng; Kelvin Cooper; David B. Damon; James Frederick Eggler; Kenneth G. Kraus; Anthony Marfat; Hiroko Masamune; J.S. Pillar; John T. Shirley; John P. Umland; John W. Watson


Archive | 2001

Pyrimidine carboxamides useful as inhibitors of PDE4 isozymes

Thomas V. Magee; Anthony Marfat; Robert James Chambers


Journal of Organic Chemistry | 1985

Stereospecific synthesis of secondary allylic alcohols: selenoxide chemistry

Phillip A. Zoretic; Robert James Chambers; Gordon Marbury; Anthony A. Riebiro


Drug Metabolism and Disposition | 2001

Pharmacokinetics and metabolism of a cysteinyl leukotriene-1 receptor antagonist from the heterocyclic chromanol series in rats: in vitro-in vivo correlation, gender-related differences, isoform identification, and comparison with metabolism in human hepatic tissue.

Alexander V. Kuperman; Amit S. Kalgutkar; Anthony Marfat; Robert James Chambers; Theodore E. Liston


Archive | 2005

PYRIMIDINECARBOXAMIDES UTILES COMME INHIBITEURS D'ISO-EZYMES PDE4, ET COMPOSITIONS LES CONTENANT

Robert James Chambers; Thomas V. Magee; Anthony Marfat


Archive | 2005

DERIVES HETEROCYCLIQUES BENZOCONDENSES DE NICOTINAMIDE, ET COMPOSITIONS LES CONTENANT

Anthony Marfat; Robert James Chambers


Archive | 2004

DERIVES DE NICOTINAMIDE NOUVEAUX, PROCEDE POUR LEUR PREPARATION ET COMPOSITIONS PHARMACEUTIQUES LES CONTENANT.

Edward Fox Kleinman; John W. Watson; John B. Cheng; Allen J. Duplantier; Anthony Marfat; Robert James Chambers


Archive | 2004

DERIVES DE NICOTINAMIDE, PROCEDE POUR LEUR PREPARATION ET COMPOSITIONS PHARMACEUTIQUES LES CONTENANT

Anthony Marfat; John W. Watson; John B. Cheng; Edward Fox Kleinman; Robert James Chambers; Allen J. Duplantier

Collaboration


Dive into the Robert James Chambers's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Byung-Chan Yu

East Carolina University

View shared research outputs
Researchain Logo
Decentralizing Knowledge